Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (251-260 of 349) with videos related to

Pageof 35
Sort By:
British Journal of Clinical Pharmacology|March 18, 2010
Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjectsKwang-Hee Shin, Yong-ju Chung, Bo-Hyung Kim, et al.
Drug Design, Development and Therapy|May 23, 2015
A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profilesHyewon Chung, Howard Lee, Hye Kyung Han, et al.
Clinical Drug Investigation|March 15, 2014
Pharmacokinetic and pharmacodynamic interaction between gemigliptin and metformin in healthy subjectsDongseong Shin, Young Min Cho, SeungHwan Lee, et al.
Clinical Drug Investigation|October 3, 2012
Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.
Epilepsia|November 19, 2011
Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsyDong Wook Kim, Nami Gu, In-Jin Jang, et al.
Diabetes, Obesity & Metabolism|October 21, 2016
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229)Jaeseong Oh, Andrew HyoungJin Kim, SeungHwan Lee, et al.
Scientific Reports|November 14, 2019
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 16, 2013
Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsyDong Wook Kim, Namyi Gu, Howard Lee, et al.
Journal of Korean Medical Science|January 1, 2019
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal ImpairmentAndrew HyoungJin Kim, Sumin Yoon, Yujin Lee, et al.
Scientific Reports|August 10, 2018
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Pageof 35

Showing results (251-260 of 349) with videos related to

Sort By:
Pageof 35
British Journal of Clinical Pharmacology|March 18, 2010
Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjectsKwang-Hee Shin, Yong-ju Chung, Bo-Hyung Kim, et al.
Drug Design, Development and Therapy|May 23, 2015
A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profilesHyewon Chung, Howard Lee, Hye Kyung Han, et al.
Clinical Drug Investigation|March 15, 2014
Pharmacokinetic and pharmacodynamic interaction between gemigliptin and metformin in healthy subjectsDongseong Shin, Young Min Cho, SeungHwan Lee, et al.
Clinical Drug Investigation|October 3, 2012
Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.
Epilepsia|November 19, 2011
Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsyDong Wook Kim, Nami Gu, In-Jin Jang, et al.
Diabetes, Obesity & Metabolism|October 21, 2016
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229)Jaeseong Oh, Andrew HyoungJin Kim, SeungHwan Lee, et al.
Scientific Reports|November 14, 2019
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 16, 2013
Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsyDong Wook Kim, Namyi Gu, Howard Lee, et al.
Journal of Korean Medical Science|January 1, 2019
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal ImpairmentAndrew HyoungJin Kim, Sumin Yoon, Yujin Lee, et al.
Scientific Reports|August 10, 2018
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Pageof 35